Altamira Therapeutics Ltd.
Hedge Funds Holdings

Last updated:

Altamira Therapeutics Ltd.‘s stocks are currently a part of 5 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 4.65K shares of Altamira Therapeutics Ltd.. Compared to the previous quarter, the number fell by -34.68% or -2.46K shares fewer. As for the holding position changes, 20% (1) of current holders sold a part of the shares held, and 20% (1) closed the holdings completely. 2 hedge funds are new holders of Altamira Therapeutics Ltd. stock in Q1 2023, it is 40% of total holders.

Hedge funds holding Altamira Therapeutics Ltd. (Q1 2021 – Q1 2023)

Number of hedge funds
Q1 2021 0
Q2 2021 0
Q3 2021 14
Q4 2021 15
Q1 2022 13
Q2 2022 10
Q3 2022 10
Q4 2022 5
Q1 2023 5

Hedge funds changes in Altamira Therapeutics Ltd. positions (Q1 2021 – Q1 2023)

Changes in positions
Q1 2021 00000
Q2 2021 00000
Q3 2021 140000
Q4 2021 4553-2
Q1 2022 3425-1
Q2 2022 3426-5
Q3 2022 5225-4
Q4 2022 50010-10
Q1 2023 20111

Hedge funds changes in Altamira Therapeutics Ltd. stock options (Q1 2021 – Q1 2023)

Changes in stock options
Q1 2021 38,000 25,000
Q2 2021 37,000 103,000
Q3 2021 45,000 6,000
Q4 2021 222,000 83,000
Q1 2022 117,000 29,000
Q2 2022 19,000 0
Q3 2022 11,000 0
Q4 2022 48,985 0
Q1 2023 0 0

Top 50 hedge fund holders of Altamira Therapeutics Ltd. (NASDAQ:CYTO)